Clinical Trials Logo

Filter by:
NCT ID: NCT00849342 Completed - Clinical trials for Diabetes Mellitus, Type 2

Observational Study on Levemir® in Obese Diabetic Patients

KILOS
Start date: December 2008
Phase: N/A
Study type: Observational

This study is conducted in Europe. The aim of this observational study is to investigate the effect of switch from other basal insulin treatments to Levemir® on body weight in obese diabetic patients. A local extension will be conducted in Slovenia in order to reach the planned 400 patients for the sub-analysis of Slovenian patients. Included in the study is a retrospective part to evaluate the weight progress since initiation of insulin treatment of another basal insulin and/or oral antidiabetic drugs (OAD) and/or bolus insulin therapy. Retrospective data will be collected at baseline and at approximately 6 and 12 months before starting insulin detemir therapy.

NCT ID: NCT00846001 Completed - Clinical trials for Ischemic Heart Failure

Resynchronization Surgery Combined Unified Efficacy

RESCUE
Start date: September 2007
Phase: Phase 3
Study type: Interventional

The purpose of the study is to compare survivability and efficacy of the patients with severe ischemic heart failure after coronary artery bypass grafting alone and coronary artery bypass grafting with single-step implantation of CRT system (CABG alone vs CABG + CRT )

NCT ID: NCT00843609 Completed - Clinical trials for Diabetes Mellitus, Type 1

International Navigator Hypoglycaemia Study

Start date: October 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if the incidence and duration of hypoglycaemia (low blood sugar) is reduced through the use of the FreeStyle Navigator Continuous Glucose Monitoring System in people with Type 1 diabetes mellitus at good glycemic control. The investigators hypothesize that the access to real-time continuous glucose concentration data along with alarms will enable people with type 1 diabetes at reasonable metabolic control to reduce the time spent in hypoglycaemia.

NCT ID: NCT00840671 Completed - Stroke Clinical Trials

Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke

CERE-LYSE-1
Start date: October 2005
Phase: Phase 3
Study type: Interventional

It should be shown that Cerebrolysin in combination with Alteplase, the medication that should recover the blood flow through the brain, is an effective and save medication to treat ischeamic stroke.

NCT ID: NCT00833456 Completed - Schizophrenia Clinical Trials

NIS to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia

Start date: February 2009
Phase: N/A
Study type: Observational

The purpose of the study is to monitor the general functional changes among patients with schizophrenia, treated with atypical antipsychotics dosed once daily for a period of 6 months.The primary study objective is to compare general functioning of patients with schizophrenia treated with Seroquel SR between baseline and the last study visit. The secondary study objectives are to compare general functioning of patients with schizophrenia treated with other atypical antipsychotic medicinal products administered once daily between baseline and the last study visit, monitoring of other indicators of clinical improvement, evaluation of patient compliance and assessment of occurrence of adverse effects

NCT ID: NCT00832182 Completed - Diabetes Clinical Trials

Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes

Start date: December 22, 1999
Phase: Phase 3
Study type: Interventional

This trial is conducted in Europe and Asia. The aim of this clinical trial is to investigate the long-term safety of insulin aspart in the management of type 1 diabetes. An extension to the ANA/DCD/065 trial

NCT ID: NCT00810069 Completed - Clinical trials for Major Depressive Disorder

Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder

Start date: November 2008
Phase: Phase 4
Study type: Interventional

This study investigates two different approaches to the change in antidepressant treatment when an initial treatment is not effective: early intervention or delayed intervention. Two hypothesis will be tested: 1. that time to confirmed response is shorter in the early intervention strategy vs. delayed intervention strategy 2. that the time to confirmed remission is shorter in the early intervention strategy compared to delayed intervention strategy.

NCT ID: NCT00802178 Completed - Parkinson Disease Clinical Trials

First Presentation of Parkinson Disease Patients to Neurologist

Start date: February 2006
Phase: N/A
Study type: Observational

In this study information is gathered about the treatment of Parkinson patients who present themselves in a neurological practice for the first time

NCT ID: NCT00790088 Completed - Clinical trials for Diabetes Mellitus, Type 1

INTERPRET - International Report on Routine Practice of Sensor-enabled Pump Therapy

Start date: February 2009
Phase:
Study type: Observational

The aim of the project is to document the international routine practice in sensor usage in patients treated with sensor-augmented pump therapy and to assess which variables (e.g. training of patients, frequency of sensor usage etc) are associated with an improvement in clinical outcome(s) from the start of the sensor use to the end of the follow-up period.

NCT ID: NCT00787657 Completed - Clinical trials for Relapsing Remitting Multiple Sclerosis (RRMS)

Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment

BEACON
Start date: June 2008
Phase: N/A
Study type: Observational

- The Study analyses the influence of selected factors on adherence to Betaferon treatment in patients with early multiple sclerosis (MS). The Investigator will document the relevant medical data regarding multiple sclerosis at every hospital visit, the patient will fill in two questionnaires at every visit: one about coping with the disease and the other about anxiety and depression. - The Study particularly looks at the role of the support of the patient given by the multiple sclerosis nurses.The nurse will provide additional standardised information at start of treatment and will regularly phone the patient to ask standardised questions about the general condition with regard to the treatment, the disease and social support. At the end of the Study it will be assessed if the supportive measures and the standards in terms of adherence management in the hospital have some influence to increase long-term treatment adherence.